In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Keith Fox
Speaker
Keith Fox
Keith Fox Keith Fox

University of Edinburgh, Edinburgh (United Kingdom of Great Britain & Northern Ireland)

Specialities : Acute Coronary Syndromes , Acute Coronary Syndromes, Coronary Artery Disease Chronic, Risk Factors and Prevention

Professor of Cardiology (University of Edinburgh) British Heart Foundation Professor (both Emeritus). Research activities include mechanisms and manifestations of thrombosis and coronary artery disease. Responsible for leading national and international trials on coronary artery disease including RITA-3 trial and GRACE. Co-Chair of large randomised trials including COMPASS, ROCKET, CHARISMA, CURE. Author of more than 700 peer reviewed publications. H index Web of Science/Scopus June 2017: 106, Google Scholar Feb 2020): H index 145. Thompson Reuters Listed as one of the top 1% of scientists “the World’s Most Influential Scientific Minds” American College of Cardiology Congress 2015: Honoured as one of four “Legends of Cardiology 2015” American Heart Association: Paul Dudley White Lecture 2015 Queen's anniversary Award to his CV Group Edinburgh 2016 ESC Silver medal 2010, ESC Gold Medal 2015

54 presentations from this speaker

Balancing risk and benefit in patients with atrial fibrillation: the GARFIELD-AF risk score

Event : ESC Congress 2019

  • Session : New approaches to risk prediction
  • Speaker : K Fox (Edinburgh,GB)

Case clinic: What would you do?

Event : ESC Congress 2019

  • Session : Vascular protection: when do patients need more?
  • Speaker : G Montalescot (Paris,FR), K Fox (Edinburgh,GB)
  • Sponsored by Bayer AG

Closing remarks

Event : ESC Congress 2019

  • Session : Vascular protection: when do patients need more?
  • Speaker : K Fox (Edinburgh,GB)
  • Sponsored by Bayer AG

Guideline update

Event : ESC Congress 2019

  • Session : Vascular protection: when do patients need more?
  • Speaker : K Fox (Edinburgh,GB), G Montalescot (Paris,FR)
  • Sponsored by Bayer AG

Innovations in risk assessment: an integrated risk tool for stroke, death and bleeding

Event : ESC Congress 2019

  • Session : What is the long term impact of atrial fibrillation? Insights from GARFIELD-AF
  • Speaker : K Fox (Edinburgh,GB)
  • Sponsored by Thrombosis Research Institute

Questions and answers and closing remarks - Vascular protection

Event : ESC Congress 2019

  • Session : Vascular protection - Which of your patients with chronic coronary artery disease will benefit?
  • Speaker : K Fox (Edinburgh,GB)
  • Sponsored by Bayer AG

Unanswered questions in acute coronary syndromes: do we know enough in 2019?

Event : ESC Congress 2019

  • Session : New strategies in acute coronary syndrome management
  • Speaker : K Fox (Edinburgh,GB)

Welcome and introduction

Event : ESC Congress 2019

  • Session : Vascular protection - Which of your patients with chronic coronary artery disease will benefit?
  • Speaker : K Fox (Edinburgh,GB)
  • Sponsored by Bayer AG

Clinical effectiveness of routine care for stroke prevention.

Event : ESC Congress 2018

  • Session : GARFIELD-AF: new light shed on atrial fibrillation and its management
  • Speaker : K Fox (Edinburgh,GB)
  • Sponsored by Thrombosis Research Institute

Closing remarks - Setting the COMPASS into new directions

Event : ESC Congress 2018

  • Session : Setting the COMPASS into new directions
  • Speaker : K Fox (Edinburgh,GB)
  • Sponsored by Bayer AG

ESC Awards Inspirational Career Lecture.

Event : ESC Congress 2018

  • Session : Awards Ceremony
  • Speaker : K Fox (Edinburgh,GB)

How can stroke prevention be improved in the elderly?

Event : ESC Congress 2018

  • Session : Translating real world evidence into your clinical practice for your multi-morbid patient
  • Speaker : K Fox (Edinburgh,GB), J Cox (Halifax,CA)
  • Sponsored by Bayer AG

Panel Discussion and Q & A.

Event : ESC Congress 2018

  • Session : New concepts in vascular protection: exploring the role of antithrombotic therapy
  • Speaker : K Fox (Edinburgh,GB)
  • Organised by Medscape Education, supported by an unrestricted grant provided by BAYER

Panel discussions and Q&A - New concepts in vascular protection: exploring the role of antithrombotic therapy.

Event : ESC Congress 2018

  • Session : New concepts in vascular protection: exploring the role of antithrombotic therapy
  • Speaker : K Fox (Edinburgh,GB)
  • Organised by Medscape Education, supported with an educational grant from BAYER AG

Presentation of the awardee.

Event : ESC Congress 2018

  • Session : ESC Rene Laennec Lecture on Clinical Cardiology
  • Speaker : K Fox (Edinburgh,GB)

The emerging concept of vascular protection: exploring the role of factor Xa inhibitors.

Event : ESC Congress 2018

  • Session : New concepts in vascular protection: exploring the role of antithrombotic therapy
  • Speaker : K Fox (Edinburgh,GB)
  • Organised by Medscape Education, supported with an educational grant from BAYER AG

The emerging concept of vascular protection: exploring the role of factor Xa inhibitors.

Event : ESC Congress 2018

  • Session : New concepts in vascular protection: exploring the role of antithrombotic therapy
  • Speaker : K Fox (Edinburgh,GB)
  • Organised by Medscape Education, supported by an unrestricted grant provided by BAYER

Welcome and introduction - New concepts in vascular protection: exploring the role of antithrombotic therapy.

Event : ESC Congress 2018

  • Session : New concepts in vascular protection: exploring the role of antithrombotic therapy
  • Speaker : K Fox (Edinburgh,GB)
  • Organised by Medscape Education, supported with an educational grant from BAYER AG

Welcome and Introduction - New concepts in vascular protection: exploring the role of antithrombotic therapy.

Event : ESC Congress 2018

  • Session : New concepts in vascular protection: exploring the role of antithrombotic therapy
  • Speaker : K Fox (Edinburgh,GB)
  • Organised by Medscape Education, supported by an unrestricted grant provided by BAYER

Why do we need additional long-term antithrombotic therapy with Coronary Artery Disease and Peripheral Artery Disease?

Event : ESC Congress 2018

  • Session : Setting the COMPASS into new directions
  • Speaker : K Fox (Edinburgh,GB)
  • Sponsored by Bayer AG

Challenging case perspectives: how would you treat?

Event : ESC Congress 2017

  • Session : NOACs and new frontiers in anticoagulation management
  • Speaker : K Fox (Edinburgh,GB)
  • Organised by Medscape Education, supported with an educational grant by Bayer

Closing remarks - Addressing the needs of the multi-morbid patients with AF.

Event : ESC Congress 2017

  • Session : Addressing the needs of the multi-morbid patients with atrial fibrillation (AF)
  • Speaker : K Fox (Edinburgh,GB), C Ruff (Boston,US)
  • Sponsored by Bayer AG

Interactive discussion... Profiling and treating the multi-morbid patient with AF.

Event : ESC Congress 2017

  • Session : Addressing the needs of the multi-morbid patients with atrial fibrillation (AF)
  • Speaker : K Fox (Edinburgh,GB), C Ruff (Boston,US)
  • Sponsored by Bayer AG

Management and outcomes in acute coronary syndromes with atrial fibrillation: where can we improve?

Event : ESC Congress 2017

  • Session : Atrial fibrillation – A bystander or cause of morbidity and mortality: insights from the GARFIELD-AF registry
  • Speaker : K Fox (Edinburgh,GB)
  • Sponsored by Thrombosis Research Institute

New insights on treating patients with atrial fibrillation (AF) who are undergoing percutaneous coronary intervention (PCI) stenting.

Event : ESC Congress 2017

  • Session : Protecting patients through responsible use of novel oral anticoagulants (NOACs)... The right dose for the right patient for stroke prevention
  • Speaker : K Fox (Edinburgh,GB)
  • Sponsored by Bayer AG

NOACs and new frontiers in anticoagulation management.

Event : ESC Congress 2017

  • Session : NOACs and new frontiers in anticoagulation management
  • Speaker : M Patel (Durham,US), J Eikelboom (Hamilton,CA), K Fox (Edinburgh,GB), F Verheugt (Amsterdam,NL)
  • Organised by Medscape Education, supported with an educational grant by Bayer

Opening remarks - Addressing the needs of the multi-morbid patients with AF.

Event : ESC Congress 2017

  • Session : Addressing the needs of the multi-morbid patients with atrial fibrillation (AF)
  • Speaker : K Fox (Edinburgh,GB), C Ruff (Boston,US)
  • Sponsored by Bayer AG

Options in thrombosis prevention and vascular health – What’s on the horizon?

Event : Heart Failure 2017

  • Session : Management of co-morbidities in heart failure - Exploring new frontiers
  • Speaker : K Fox (Edinburgh,GB)
  • Sponsored by Bayer AG

Keynote lecture: Vulnerable plaques in vulnerable patients.

Event : Acute Cardiovascular Care 2016

  • Session : Inaugural session
  • Speaker : K Fox (Edinburgh,GB)

PRAGUE -18 - Discussant review.

Event : ESC Congress 2016

  • Session : Hot Line coronary artery disease and stenting
  • Speaker : K Fox (Edinburgh,GB)

Risk scores for patients with nonvalvular AF.

Event : ESC Congress 2016

  • Session : Risk profiles for patients with atrial fibrillation and the quality of stroke prevention: results from the GARFIELD-AF registry
  • Speaker : K Fox (Edinburgh,GB)
  • Sponsored by Thrombosis Research Institute

Close - Dual anti-platelet therapy in atherothrombosis in 2015: debating the evidence.

Event : ESC Congress 2015

  • Session : Dual anti-platelet therapy in atherothrombosis in 2015: debating the evidence
  • Speaker : K Fox (Edinburgh,GB)
  • Organised by University Hospital of Umea Course Director: Ulf Naslund Supported by an unrestricted educational grant from AstraZeneca

Discussion - Dual anti-platelet therapy in atherothrombosis in 2015: debating the evidence.

Event : ESC Congress 2015

  • Session : Dual anti-platelet therapy in atherothrombosis in 2015: debating the evidence
  • Speaker : K Fox (Edinburgh,GB), C Hamm (Bad Nauheim,DE), M Sabatine (Boston,US), N Danchin (Montreuil,FR)
  • Organised by University Hospital of Umea Course Director: Ulf Naslund Supported by an unrestricted educational grant from AstraZeneca

My scientific journey.

Event : ESC Congress 2015

  • Session : Meet the Legends - Keith Fox
  • Speaker : K Fox (Edinburgh,GB)

Open forum discussion.

Event : ESC Congress 2015

  • Session : Meet the Legends - Keith Fox
  • Speaker : K Fox (Edinburgh,GB)

Open questions - Dual anti-platelet therapy in atherothrombosis in 2015: debating the evidence.

Event : ESC Congress 2015

  • Session : Dual anti-platelet therapy in atherothrombosis in 2015: debating the evidence
  • Speaker : K Fox (Edinburgh,GB), C Hamm (Bad Nauheim,DE)
  • Organised by University Hospital of Umea Course Director: Ulf Naslund Supported by an unrestricted educational grant from AstraZeneca

Securing quality in registries and a review of GARFIELD-AF data.

Event : ESC Congress 2015

  • Session : Anticoagulation and Atrial Fibrillation (AF): real life data from the GARFIELD-AF Registry
  • Speaker : K Fox (Edinburgh,GB)
  • Sponsored by Thrombosis Research Institute London

Stroke prevention in high-risk patients with atrial fibrillation in clinical trials.

Event : ESC Congress 2015

  • Session : Preventing atrial fibrillation-related strokes and recurrent acute coronary syndromes: combining evidence from clinical trials and real life
  • Speaker : K Fox (Edinburgh,GB)
  • Sponsored by Bayer HealthCare

Welcome and introduction - Dual anti-platelet therapy in atherothrombosis in 2015: debating the evidence.

Event : ESC Congress 2015

  • Session : Dual anti-platelet therapy in atherothrombosis in 2015: debating the evidence
  • Speaker : K Fox (Edinburgh,GB)
  • Organised by University Hospital of Umea Course Director: Ulf Naslund Supported by an unrestricted educational grant from AstraZeneca

Welcome and session objectives - Dual anti-platelet therapy in atherothrombosis in 2015: debating the evidence.

Event : ESC Congress 2015

  • Session : Dual anti-platelet therapy in atherothrombosis in 2015: debating the evidence
  • Speaker : K Fox (Edinburgh,GB)
  • Organised by University Hospital of Umea Course Director: Ulf Naslund Supported by an unrestricted educational grant from AstraZeneca

Concluding remarks - Out with the old and in with the new in heart failure: new insights and new targets.

Event : ESC Congress 2014

  • Session : Out with the old and in with the new in heart failure: new insights and new targets
  • Speaker : K Fox (Edinburgh,GB)
  • Sponsored by Medscape / theheart.org

ESC Congress 2014 Awards.

Event : ESC Congress 2014

  • Session : Highlight session
  • Speaker : K Fox (Edinburgh,GB)

Panel.

Event : ESC Congress 2014

  • Session : PARADIGM-HF: The experts' discussion
  • Speaker : JJV McMurray (Glasgow,GB), M Packer (Dallas,US), K Fox (Edinburgh,GB), M Komajda (Paris,FR)

The case of the broken heart revisited.

Event : ESC Congress 2014

  • Session : Out with the old and in with the new in heart failure: new insights and new targets
  • Speaker : K Fox (Edinburgh,GB)
  • Sponsored by Medscape / theheart.org

The case of the broken heart.

Event : ESC Congress 2014

  • Session : Out with the old and in with the new in heart failure: new insights and new targets
  • Speaker : K Fox (Edinburgh,GB)
  • Sponsored by Medscape / theheart.org

The role of anticoagulants.

Event : ESC Congress 2014

  • Session : Anticoagulation and atrial fibrillation: emerging insights
  • Speaker : K Fox (Edinburgh,GB)
  • Sponsored by Thrombosis Research Institute London

X-VeRT: Panel discussion

Event : ESC Congress 2014

  • Session : Hot Line: Coronary artery disease and atrial fibrillation
  • Speaker : K Fox (Edinburgh,GB)

Acute coronary syndromes: role of the clinical phenotype and of the risk scores.

Event : ESC Congress 2013

  • Session : Towards a more personalised cardiology: outcomes of an ESC workshop. The role of 'personalised medicine' in...
  • Speaker : K Fox (Edinburgh,GB)

Clinical challenges: anticoagulation management of patients with AF and ACS.

Event : ESC Congress 2013

  • Session : Novel oral anticoagulants and the cardiologist – Taking pivotal trial evidence into real-world practice
  • Speaker : K Fox (Edinburgh,GB)
  • Sponsored by Bayer HealthCare

ESC Congress 2013 Awards.

Event : ESC Congress 2013

  • Session : Highlight Session
  • Speaker : K Fox (Edinburgh,GB)

FAST-MI & GRACE: First external and long-term validation in the FAST-MI registry of the updated electronic GRACE risk score.

Event : ESC Congress 2013

  • Session : Registry Hot Line: Registries on risks, therapies and outcomes
  • Speaker : K Fox (Edinburgh,GB)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are